Alzheimer's disease (AD) is a neurodegenerative disorder considered as a global public
health threat influencing many people. Despite the concerning rise in the affected …

Treatment of Alzheimer's Disease is currently limited only to slowing the progression of the
symptoms, not curing the disease. Current FDA-approved therapies such as Donepezil …

Background: Breast cancer is the most commonly diagnosed and major cause of cancer-
related deaths in women worldwide. Disruption of the normal regulation of cell cycle …

The pathogenic complexity of Alzheimer's disease (AD) demands the development of
multitarget‐directed agents aiming at improving actual pharmacotherapy. Based on the …

The inhibition of acetylcholinesterase plays a vital role in the treatment of Alzheimer disease.
This study aimed to explore the acetylcholinesterase inhibition potential of Phyllanthus …

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease that affects
people aged 60 years and above. Yet, the discovery of potent therapeutic agents against …

Alzheimer's disease is among the major health challenges that currently attract the attention
of health care givers and drug discovery and development experts worldwide. This study …

Background: Computational methods in the 'omics' era have proved to be a boon in the drug
discovery field. Bioinformatics and cheminformatics databases and tools complement the …

In silico techniques reduce the need for rigorous animal experimentations. It is time-efficient,
eco-friendly, sustainable, and also adheres to the principle of green chemistry. In silico …

Alzheimer's disease is a complex neurodegenerative ailment accompanied by cognitive
problems and progressive memory loss. The main causes of the disease are …